Skip to content
healthcare.dev

haloperidol decanoate

NDC 25021-834, haloperidol decanoate, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-834
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205241
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-834 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HALOPERIDOL DECANOATE500 mg/5mL

Pharmacologic classes

Typical Antipsychotic [EPC]

Package NDCNDC-11Package
25021-834-05250210834051 VIAL in 1 CARTON (25021-834-05) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b3167043-585f-482f-b8a7-591bc2721bd3
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-834
  • NADAC price for package 25021083405

    GET /v1/drugs/nadac/25021083405

Use it

Look up 25021-834 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-834 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-834. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.